Lindahl advised Nanologica on the offering. Nanologica finalized a rights issuance, which was resolved by the board of directors on 29 August 2024 and approved by...
You must be a Standard 1 Year member to access this content.
Lindahl acted as legal advisor to Corline Biomedical in connection with the license agreement with the California-based company Imperative Care. The agreement concerns license rights to...
You must be a Standard 1 Year member to access this content.
Lindahl advised Senzime AB on the deal. Senzime AB (publ) announced a rights issue which was resolved by the board of directors on 23 January 2023 and...
You must be a Standard 1 Year member to access this content.
Lindahl assisted the owners of Corplus AB and Corplus Syd AB. Broviken Gruppen, which owns and develops qualified service companies, became principal owner of Corplus. The transaction...
You must be a Standard 1 Year member to access this content.
Lindahl advised Nanologica AB on the deal. Nanologica AB announced the company’s list change from Spotlight Stock Market to Nasdaq Stockholm’s main market. Nanologica manufactures, develops, and...
You must be a Standard 1 Year member to access this content.
Vinge advised Electra Gruppen on the deal, while Lindahl has represented Elon Group. Electra Gruppen AB, listed on Nasdaq Stockholm, and Elon Group Holding AB (publ) entered...
You must be a Standard 1 Year member to access this content.
Lindahl advised KitchenTime on the deal. Bergendahl & Son AB has entered into an investment agreement regarding KitchenTime AB, where Bergendahl becomes the owner of 53% of...
You must be a Standard 1 Year member to access this content.
